Genmab A/S

GMAB

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001434265

SEC filings (opens in a new tab)

No open-market purchases or sales by Genmab A/S insiders were filed in the last 90 days; 291 institutions reported holding it in 13F filings for Q2 2026, worth $2.81B in total; no superinvestor holds it.

Other share classesGNMSF

Q3 2024 vs. Q2 2024

How the institutions holding Genmab A/S changed between Q2 2024 and Q3 2024.

All holders in Q3 2024 All holders in Q2 2024

13F holders of GMAB: Q2 2024 compared with Q3 2024
Measure	Q2 2024	Of which not filed for Q3 2024	Q3 2024	Change
Holders	220	2	224	+6
Shares	48.7M	5.09M	52.3M	+8.66M (+19.8%)
Value	$1.23B	$127.9M	$1.27B	+$173.2M (+15.8%)

2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (30)

Institutions that held Genmab A/S at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to GMAB in Q3 2024
Institution	Shares	Value	% of portfolio
BlackRock, Inc.	4,616,963	$112.6M	0.00%
Orbis Allan Gray Ltd	1,676,793	$40.9M	0.22%
Balyasny Asset Management LLC	212,663	$5.18M	0.01%
Verition Fund Management LLC	29,074	$708.8K	0.00%
Sterling Capital Management LLC	24,408	$595.1K	0.01%
International Assets Investment Management, LLC	10,410	$427.0K	0.00%
O'Shaughnessy Asset Management, LLC	17,503	$414.1K	0.00%
Ritholtz Wealth Management	12,869	$313.7K	0.01%
Wiley Bros.-Aintree Capital, LLC	11,918	$290.4K	0.01%
HighTower Advisors, LLC	11,384	$273.0K	0.00%
Baldwin Brothers Inc	11,172	$272.4K	0.02%
Wealth Alliance	10,043	$244.8K	0.03%
Vise Technologies, Inc.	9,098	$221.8K	0.03%
Squarepoint Ops LLC	8,802	$214.6K	0.00%
Vident Advisory, LLC	8,388	$204.5K	0.01%
Congress Wealth Management LLC	8,330	$203.1K	0.00%
Strategic Global Advisors, LLC	8,320	$202.8K	0.04%
Mount Yale Investment Advisors, LLC	7,883	$192.2K	0.02%
Simplex Trading, LLC	2,170	$52.0K	0.00%
Alpine Bank Wealth Management	709	$17.3K	0.00%
Bryn Mawr Trust Co	388	$9.46K	0.00%
Global Financial Private Client, LLC	383	$9.34K	0.00%
Cullen/Frost Bankers, Inc.	146	$3.56K	0.00%
Bogart Wealth, LLC	146	$3.56K	0.00%
Bessemer Group Inc	126	$3.00K	0.00%
Reston Wealth Management LLC	54	$1.32K	0.00%
Concord Wealth Partners	49	$1.20K	0.00%
Grove Bank & Trust	42	$1.02K	0.00%
Central Trust Co	7	$173	0.00%
Mediolanum International Funds Ltd	28,661	–	–

Sold out (24)

Institutions that held Genmab A/S at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of GMAB in Q3 2024
Institution	Shares, Q2 2024	Value, Q2 2024
Cubist Systematic Strategies, LLC	278,541	$7.00M
Royal London Asset Management Ltd	49,849	$1.25M
Simplicity Wealth,LLC	28,480	$715.7K
Aquatic Capital Management LLC	27,600	$693.6K
Point72 Asset Management, L.P.	18,184	$457.0K
Jane Street Group, LLC	14,368	$361.1K
Greenleaf Trust	13,230	$332.5K
HRT Financial LP	10,351	$260.0K
Aigen Investment Management, LP	10,053	$252.6K
Glenmede Trust Co NA	8,698	$218.6K
Kestra Advisory Services, LLC	8,189	$205.8K
Headlands Technologies LLC	5,138	$129.1K
SYSTM Wealth Solutions LLC	1,447	$36.4K
Point72 Hong Kong Ltd	234	$5.89K
Ashton Thomas Private Wealth, LLC	202	$5.08K
Washington Trust Advisors, Inc.	167	$4.20K
RFP Financial Group LLC	156	$3.92K
Front Row Advisors LLC	154	$3.87K
Whittier Trust Co	110	$2.76K
Point72 (DIFC) Ltd	77	$1.92K
TD Waterhouse Canada Inc.	33	$820
Opal Wealth Advisors, LLC	30	$754
Lynx Investment Advisory	21	$528
Zions Bancorporation, N.A.	18	$452

Not filed for Q3 2024 yet (2)

Institutions that held Genmab A/S at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding GMAB in Q2 2024 that haven't filed for Q3 2024
Institution	Shares, Q2 2024	Value, Q2 2024
BlackRock Inc.	5,080,562	$127.7M
Benjamin F. Edwards & Company, Inc.	7,227	$182.0K